Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-08

AUTHORS

Marc C. Chamberlain

ABSTRACT

Treatment of leptomeningeal metastasis (LMD) remains challenging due to advanced systemic disease at presentation and limited treatment options. All patients underwent standard pre-treatment LMD evaluation including CSF assessment (cytology or flow cytometry), brain and spine MR imaging, and radioisotope CSF flow study. DepoCyt (liposomal cytarabine) was administered intraventricularly (n = 80) or intralumbar (n = 40) at 50 mg every 2 weeks × 4 and then every 4 weeks × 6 in responding patients. Dexamethasone (4 mg orally twice per day × 5 days) was co-administered with each DepoCyt treatment. Patients were seen with each DepoCyt treatment and assessed for toxicity. 120 adult patients [median age 51 years (range 33-68)] with LMD were treated with DepoCyt. DepoCyt Common Toxicity Criteria ≥ Grade 3 neurotoxicity was seen in 60 cycles (11.5 %) in 28 patients (23.3 %). Toxicity included bacterial meningitis (3.75 % of ventricular treatments: 0 % of lumbar treatments); chemical meningitis (17.5:15 %); communicating hydrocephalus (3.75:5 %); conus medullaris/cauda equina syndrome (5:5 %); decreased visual acuity (5:2.5 %); encephalopathy (5:5 %); leukoencephalopathy (7.5:2.5 %); myelopathy (2.5:2.5 %); radiculopathy (1.25:5 %); and seizures (1.25:2.5 %). Distribution of toxicity was similar regardless of route of administration (ventricular vs. lumbar). Toxicities were transient in 34 episodes (57 %) and permanent in 26 (43 %). There were no treatment-related deaths however 20 treatment-related toxicities (32.2 %) required hospitalization. In this retrospective case series, DepoCyt is generally well tolerated however a subset of patients (12.5 %) not easily identified pre-treatment, develop serious treatment-related neurological complications that may be persistent and impact quality of life. More... »

PAGES

143-148

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-012-0880-x

DOI

http://dx.doi.org/10.1007/s11060-012-0880-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043012246

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22539243


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Spinal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liposomes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meningeal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurotoxicity Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fred Hutchinson Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.270240.3", 
          "name": [
            "Department of Neurology and Neurosurgery, University of Washington, Seattle, WA, USA", 
            "Seattle Cancer Care Alliance, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, MS: G4-940, 98109, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1227/01.neu.0000043929.31608.62", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006566228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0435-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007686260", 
          "https://doi.org/10.1007/s11060-010-0435-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-199141050-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012608210", 
          "https://doi.org/10.2165/00003495-199141050-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22619", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012813205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-08-043646", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013778504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19941201)74:11<3034::aid-cncr2820741122>3.0.co;2-o", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014827768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014922900"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200544010-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015562806", 
          "https://doi.org/10.2165/00003088-200544010-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200544010-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015562806", 
          "https://doi.org/10.2165/00003088-200544010-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2010.028092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020718368"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-008-0546-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023295964", 
          "https://doi.org/10.1007/s00277-008-0546-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-008-0546-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023295964", 
          "https://doi.org/10.1007/s00277-008-0546-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-008-9707-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023545868", 
          "https://doi.org/10.1007/s11060-008-9707-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.55.4.506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027662249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11912-003-0085-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034846460", 
          "https://doi.org/10.1007/s11912-003-0085-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2004.08.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037122701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-008-0645-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051003704", 
          "https://doi.org/10.1007/s00277-008-0645-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-008-0645-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051003704", 
          "https://doi.org/10.1007/s00277-008-0645-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.49.6.1728", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064375612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.49.6.1728", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064375612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.49.6.1728", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064375612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1997.87.5.0694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071098588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1997.87.5.0694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071098588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1997.87.5.0694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071098588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.9.3.505", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071517881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/or.5.2.521", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071535656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.10.3110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074528546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074559836", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-08", 
    "datePublishedReg": "2012-08-01", 
    "description": "Treatment of leptomeningeal metastasis (LMD) remains challenging due to advanced systemic disease at presentation and limited treatment options. All patients underwent standard pre-treatment LMD evaluation including CSF assessment (cytology or flow cytometry), brain and spine MR imaging, and radioisotope CSF flow study. DepoCyt (liposomal cytarabine) was administered intraventricularly (n = 80) or intralumbar (n = 40) at 50 mg every 2 weeks \u00d7 4 and then every 4 weeks \u00d7 6 in responding patients. Dexamethasone (4 mg orally twice per day \u00d7 5 days) was co-administered with each DepoCyt treatment. Patients were seen with each DepoCyt treatment and assessed for toxicity. 120 adult patients [median age 51 years (range 33-68)] with LMD were treated with DepoCyt. DepoCyt Common Toxicity Criteria \u2265 Grade 3 neurotoxicity was seen in 60 cycles (11.5 %) in 28 patients (23.3 %). Toxicity included bacterial meningitis (3.75 % of ventricular treatments: 0 % of lumbar treatments); chemical meningitis (17.5:15 %); communicating hydrocephalus (3.75:5 %); conus medullaris/cauda equina syndrome (5:5 %); decreased visual acuity (5:2.5 %); encephalopathy (5:5 %); leukoencephalopathy (7.5:2.5 %); myelopathy (2.5:2.5 %); radiculopathy (1.25:5 %); and seizures (1.25:2.5 %). Distribution of toxicity was similar regardless of route of administration (ventricular vs. lumbar). Toxicities were transient in 34 episodes (57 %) and permanent in 26 (43 %). There were no treatment-related deaths however 20 treatment-related toxicities (32.2 %) required hospitalization. In this retrospective case series, DepoCyt is generally well tolerated however a subset of patients (12.5 %) not easily identified pre-treatment, develop serious treatment-related neurological complications that may be persistent and impact quality of life.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-012-0880-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "109"
      }
    ], 
    "name": "Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series", 
    "pagination": "143-148", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "cce1de98a4dcef2f1bf708a353e5e1e3ad35a4b5518980e0b6cf0f660e7fcae9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22539243"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-012-0880-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043012246"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-012-0880-x", 
      "https://app.dimensions.ai/details/publication/pub.1043012246"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000534.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-012-0880-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0880-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0880-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0880-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0880-x'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      21 PREDICATES      70 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-012-0880-x schema:about N041b5b54475b4f16a286f6fd5027b016
2 N1b436fc8573545d4aaf69356ebab4b89
3 N1dbba1060b7c491d9e6e83a95be2ad7a
4 N211a08c60cdd45ccac9adbce54e43fed
5 N2307b578de4e4bc6be77fb62d95fd163
6 N28d16ad8b15540ceb6cd73e1413528c9
7 N3dc31e99b61440e68fcaee8411397463
8 N3fd7ca75923142248dc9130110b77730
9 N488ef81ae76e490b827f7202b83be925
10 N5411ab0dd30e48da8097b7a3758cc00a
11 N5dffeb67f5b9434d9b23cee6a5bcfed9
12 N6c5d7afb19644672be48330ea084e43f
13 N6d7d82e3bed54094bc1accbc106b84a9
14 N77febb0a9dea4822b85950cb55de4725
15 N812eb6e6578242c69e89b0b37f5152a3
16 N9a3eb794f4e746e0bd6c4e4256577e4b
17 Nc54e365201da42aea8bd711829dfad3e
18 Nd1990c99116a495d80e7ce0ce55cee08
19 Nd75a1518c70349e981c564f193d6cbda
20 Nf98e8b066e834098af61bb1b70e4bbeb
21 anzsrc-for:11
22 anzsrc-for:1109
23 schema:author N582f9d29ef754e7aadcdcabf64752792
24 schema:citation sg:pub.10.1007/s00277-008-0546-0
25 sg:pub.10.1007/s00277-008-0645-y
26 sg:pub.10.1007/s11060-008-9707-1
27 sg:pub.10.1007/s11060-010-0435-y
28 sg:pub.10.1007/s11912-003-0085-8
29 sg:pub.10.2165/00003088-200544010-00001
30 sg:pub.10.2165/00003495-199141050-00003
31 https://app.dimensions.ai/details/publication/pub.1074559836
32 https://doi.org/10.1001/archneur.55.4.506
33 https://doi.org/10.1002/1097-0142(19941201)74:11<3034::aid-cncr2820741122>3.0.co;2-o
34 https://doi.org/10.1002/cncr.22619
35 https://doi.org/10.1002/cncr.23330
36 https://doi.org/10.1016/j.ejca.2004.08.012
37 https://doi.org/10.1182/blood-2006-08-043646
38 https://doi.org/10.1200/jco.1999.17.10.3110
39 https://doi.org/10.1212/wnl.49.6.1728
40 https://doi.org/10.1227/01.neu.0000043929.31608.62
41 https://doi.org/10.3171/jns.1997.87.5.0694
42 https://doi.org/10.3324/haematol.2010.028092
43 https://doi.org/10.3892/ijo.9.3.505
44 https://doi.org/10.3892/or.5.2.521
45 schema:datePublished 2012-08
46 schema:datePublishedReg 2012-08-01
47 schema:description Treatment of leptomeningeal metastasis (LMD) remains challenging due to advanced systemic disease at presentation and limited treatment options. All patients underwent standard pre-treatment LMD evaluation including CSF assessment (cytology or flow cytometry), brain and spine MR imaging, and radioisotope CSF flow study. DepoCyt (liposomal cytarabine) was administered intraventricularly (n = 80) or intralumbar (n = 40) at 50 mg every 2 weeks × 4 and then every 4 weeks × 6 in responding patients. Dexamethasone (4 mg orally twice per day × 5 days) was co-administered with each DepoCyt treatment. Patients were seen with each DepoCyt treatment and assessed for toxicity. 120 adult patients [median age 51 years (range 33-68)] with LMD were treated with DepoCyt. DepoCyt Common Toxicity Criteria ≥ Grade 3 neurotoxicity was seen in 60 cycles (11.5 %) in 28 patients (23.3 %). Toxicity included bacterial meningitis (3.75 % of ventricular treatments: 0 % of lumbar treatments); chemical meningitis (17.5:15 %); communicating hydrocephalus (3.75:5 %); conus medullaris/cauda equina syndrome (5:5 %); decreased visual acuity (5:2.5 %); encephalopathy (5:5 %); leukoencephalopathy (7.5:2.5 %); myelopathy (2.5:2.5 %); radiculopathy (1.25:5 %); and seizures (1.25:2.5 %). Distribution of toxicity was similar regardless of route of administration (ventricular vs. lumbar). Toxicities were transient in 34 episodes (57 %) and permanent in 26 (43 %). There were no treatment-related deaths however 20 treatment-related toxicities (32.2 %) required hospitalization. In this retrospective case series, DepoCyt is generally well tolerated however a subset of patients (12.5 %) not easily identified pre-treatment, develop serious treatment-related neurological complications that may be persistent and impact quality of life.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree false
51 schema:isPartOf N0e7fe3615c304e1c9495d3f565f0f42e
52 N7c5a4e9a83bb443db93d8008d680529b
53 sg:journal.1094205
54 schema:name Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series
55 schema:pagination 143-148
56 schema:productId N0d9a012c99c542f380fcac15a05c3556
57 N230179faf58849eba8c1dcba99cb7d6d
58 N422ee3b654924a93a688bffea5d3b88e
59 N8d9696a7c45d4750a0f5d2fb24b47c38
60 N98a89c92635b4a098a9335c81eb416bd
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043012246
62 https://doi.org/10.1007/s11060-012-0880-x
63 schema:sdDatePublished 2019-04-10T15:05
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N0e77728382fa46bcbc5a8588a4aabb23
66 schema:url http://link.springer.com/10.1007%2Fs11060-012-0880-x
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N041b5b54475b4f16a286f6fd5027b016 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Follow-Up Studies
72 rdf:type schema:DefinedTerm
73 N0d9a012c99c542f380fcac15a05c3556 schema:name pubmed_id
74 schema:value 22539243
75 rdf:type schema:PropertyValue
76 N0e77728382fa46bcbc5a8588a4aabb23 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N0e7fe3615c304e1c9495d3f565f0f42e schema:volumeNumber 109
79 rdf:type schema:PublicationVolume
80 N1b436fc8573545d4aaf69356ebab4b89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Meningeal Neoplasms
82 rdf:type schema:DefinedTerm
83 N1dbba1060b7c491d9e6e83a95be2ad7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Neoplasm Staging
85 rdf:type schema:DefinedTerm
86 N211a08c60cdd45ccac9adbce54e43fed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Adult
88 rdf:type schema:DefinedTerm
89 N230179faf58849eba8c1dcba99cb7d6d schema:name readcube_id
90 schema:value cce1de98a4dcef2f1bf708a353e5e1e3ad35a4b5518980e0b6cf0f660e7fcae9
91 rdf:type schema:PropertyValue
92 N2307b578de4e4bc6be77fb62d95fd163 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N28d16ad8b15540ceb6cd73e1413528c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Neurotoxicity Syndromes
97 rdf:type schema:DefinedTerm
98 N3dc31e99b61440e68fcaee8411397463 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Liposomes
100 rdf:type schema:DefinedTerm
101 N3fd7ca75923142248dc9130110b77730 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Retrospective Studies
103 rdf:type schema:DefinedTerm
104 N422ee3b654924a93a688bffea5d3b88e schema:name nlm_unique_id
105 schema:value 8309335
106 rdf:type schema:PropertyValue
107 N488ef81ae76e490b827f7202b83be925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Female
109 rdf:type schema:DefinedTerm
110 N5411ab0dd30e48da8097b7a3758cc00a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Disease Progression
112 rdf:type schema:DefinedTerm
113 N582f9d29ef754e7aadcdcabf64752792 rdf:first sg:person.01326261166.36
114 rdf:rest rdf:nil
115 N5dffeb67f5b9434d9b23cee6a5bcfed9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Neoplasms
117 rdf:type schema:DefinedTerm
118 N6c5d7afb19644672be48330ea084e43f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Prognosis
120 rdf:type schema:DefinedTerm
121 N6d7d82e3bed54094bc1accbc106b84a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Magnetic Resonance Imaging
123 rdf:type schema:DefinedTerm
124 N77febb0a9dea4822b85950cb55de4725 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Aged
126 rdf:type schema:DefinedTerm
127 N7c5a4e9a83bb443db93d8008d680529b schema:issueNumber 1
128 rdf:type schema:PublicationIssue
129 N812eb6e6578242c69e89b0b37f5152a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Injections, Spinal
131 rdf:type schema:DefinedTerm
132 N8d9696a7c45d4750a0f5d2fb24b47c38 schema:name dimensions_id
133 schema:value pub.1043012246
134 rdf:type schema:PropertyValue
135 N98a89c92635b4a098a9335c81eb416bd schema:name doi
136 schema:value 10.1007/s11060-012-0880-x
137 rdf:type schema:PropertyValue
138 N9a3eb794f4e746e0bd6c4e4256577e4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Prospective Studies
140 rdf:type schema:DefinedTerm
141 Nc54e365201da42aea8bd711829dfad3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Cytarabine
143 rdf:type schema:DefinedTerm
144 Nd1990c99116a495d80e7ce0ce55cee08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Antimetabolites, Antineoplastic
146 rdf:type schema:DefinedTerm
147 Nd75a1518c70349e981c564f193d6cbda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 Nf98e8b066e834098af61bb1b70e4bbeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Middle Aged
152 rdf:type schema:DefinedTerm
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
157 schema:name Neurosciences
158 rdf:type schema:DefinedTerm
159 sg:journal.1094205 schema:issn 0167-594X
160 1573-7373
161 schema:name Journal of Neuro-Oncology
162 rdf:type schema:Periodical
163 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.270240.3
164 schema:familyName Chamberlain
165 schema:givenName Marc C.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
167 rdf:type schema:Person
168 sg:pub.10.1007/s00277-008-0546-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023295964
169 https://doi.org/10.1007/s00277-008-0546-0
170 rdf:type schema:CreativeWork
171 sg:pub.10.1007/s00277-008-0645-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1051003704
172 https://doi.org/10.1007/s00277-008-0645-y
173 rdf:type schema:CreativeWork
174 sg:pub.10.1007/s11060-008-9707-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023545868
175 https://doi.org/10.1007/s11060-008-9707-1
176 rdf:type schema:CreativeWork
177 sg:pub.10.1007/s11060-010-0435-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1007686260
178 https://doi.org/10.1007/s11060-010-0435-y
179 rdf:type schema:CreativeWork
180 sg:pub.10.1007/s11912-003-0085-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034846460
181 https://doi.org/10.1007/s11912-003-0085-8
182 rdf:type schema:CreativeWork
183 sg:pub.10.2165/00003088-200544010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015562806
184 https://doi.org/10.2165/00003088-200544010-00001
185 rdf:type schema:CreativeWork
186 sg:pub.10.2165/00003495-199141050-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012608210
187 https://doi.org/10.2165/00003495-199141050-00003
188 rdf:type schema:CreativeWork
189 https://app.dimensions.ai/details/publication/pub.1074559836 schema:CreativeWork
190 https://doi.org/10.1001/archneur.55.4.506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027662249
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1002/1097-0142(19941201)74:11<3034::aid-cncr2820741122>3.0.co;2-o schema:sameAs https://app.dimensions.ai/details/publication/pub.1014827768
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1002/cncr.22619 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012813205
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1002/cncr.23330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014922900
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.ejca.2004.08.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037122701
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1182/blood-2006-08-043646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013778504
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1200/jco.1999.17.10.3110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074528546
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1212/wnl.49.6.1728 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064375612
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1227/01.neu.0000043929.31608.62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006566228
207 rdf:type schema:CreativeWork
208 https://doi.org/10.3171/jns.1997.87.5.0694 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071098588
209 rdf:type schema:CreativeWork
210 https://doi.org/10.3324/haematol.2010.028092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020718368
211 rdf:type schema:CreativeWork
212 https://doi.org/10.3892/ijo.9.3.505 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071517881
213 rdf:type schema:CreativeWork
214 https://doi.org/10.3892/or.5.2.521 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071535656
215 rdf:type schema:CreativeWork
216 https://www.grid.ac/institutes/grid.270240.3 schema:alternateName Fred Hutchinson Cancer Research Center
217 schema:name Department of Neurology and Neurosurgery, University of Washington, Seattle, WA, USA
218 Seattle Cancer Care Alliance, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, MS: G4-940, 98109, Seattle, WA, USA
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...